Patwa VC - Search Results

1

Epidermal growth factor receptor-dependent maintenance of cardiac contractility.

Guo S, Okyere AD, McEachern E, Strong JL, Carter RL, Patwa VC, Thomas TP, Landy M, Song J, Lucchese AM, Martin TG, Gao E, Rajan S, Kirk JA, Koch WJ, Cheung JY, Tilley DG. Guo S, et al. Among authors: patwa vc. Cardiovasc Res. 2022 Mar 25;118(5):1276-1288. doi: 10.1093/cvr/cvab149. Cardiovasc Res. 2022. PMID: 33892492 Free PMC article.

2

ADP exerts P2Y₁₂ -dependent and P2Y₁₂ -independent effects on primary human T cell responses to stimulation.

Vemulapalli H, Albayati S, Patwa VC, Tilley DG, Tsygankov AY, Liverani E. Vemulapalli H, et al. Among authors: patwa vc. J Cell Commun Signal. 2020 Mar;14(1):111-126. doi: 10.1007/s12079-019-00540-8. Epub 2019 Dec 5. J Cell Commun Signal. 2020. PMID: 31808055 Free PMC article.

3

Epidermal growth factor receptor association with β1-adrenergic receptor is mediated via its juxtamembrane domain.

Patwa V, Guo S, Carter RL, Kraus L, Einspahr J, Teplitsky D, Sabri A, Tilley DG. Patwa V, et al. Cell Signal. 2021 Feb;78:109846. doi: 10.1016/j.cellsig.2020.109846. Epub 2020 Nov 22. Cell Signal. 2021. PMID: 33238186 Free PMC article.

4

Pepducin ICL1-9-Mediated β2-Adrenergic Receptor-Dependent Cardiomyocyte Contractility Occurs in a G_i Protein/ROCK/PKD-Sensitive Manner.

Okyere AD, Song J, Patwa V, Carter RL, Enjamuri N, Lucchese AM, Ibetti J, de Lucia C, Schumacher SM, Koch WJ, Cheung JY, Benovic JL, Tilley DG. Okyere AD, et al. Cardiovasc Drugs Ther. 2023 Apr;37(2):245-256. doi: 10.1007/s10557-021-07299-4. Epub 2022 Jan 8. Cardiovasc Drugs Ther. 2023. PMID: 34997361 Free PMC article.

5

[No title available]

[No authors listed] [No authors listed] PMID: 35553052

6

Myeloid cell-specific deletion of epidermal growth factor receptor aggravates acute cardiac injury.

Okyere AD, Nayak TK, Patwa V, Teplitsky D, McEachern E, Carter RL, Xu H, Gao E, Zhou Y, Tilley DG. Okyere AD, et al. Clin Sci (Lond). 2023 Oct 11;137(19):1513-1531. doi: 10.1042/CS20230804. Clin Sci (Lond). 2023. PMID: 37728308 Free PMC article.

7

Plecanatide-mediated activation of guanylate cyclase-C suppresses inflammation-induced colorectal carcinogenesis in Apc^+/Min-FCCC mice.

Chang WL, Masih S, Thadi A, Patwa V, Joshi A, Cooper HS, Palejwala VA, Clapper ML, Shailubhai K. Chang WL, et al. World J Gastrointest Pharmacol Ther. 2017 Feb 6;8(1):47-59. doi: 10.4292/wjgpt.v8.i1.47. World J Gastrointest Pharmacol Ther. 2017. PMID: 28217374 Free PMC article.

8

Oral treatment with plecanatide or dolcanatide attenuates visceral hypersensitivity via activation of guanylate cyclase-C in rat models.

Boulete IM, Thadi A, Beaufrand C, Patwa V, Joshi A, Foss JA, Eddy EP, Eutamene H, Palejwala VA, Theodorou V, Shailubhai K. Boulete IM, et al. World J Gastroenterol. 2018 May 7;24(17):1888-1900. doi: 10.3748/wjg.v24.i17.1888. World J Gastroenterol. 2018. PMID: 29740204 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8 results

Search Page